Pharmacokinetics of bacampicillin tablets in adults.

Por Craig, W. A.
Publicado em 1983

In Vivo Activities of Amoxicillin and Amoxicillin-Clavulanate against Streptococcus pneumoniae: Application to Breakpoint Determinations

Por Andes, D., Craig, W. A.
Publicado em 1998

Pharmacodynamics of the New Fluoroquinolone Gatifloxacin in Murine Thigh and Lung Infection Models

Por Andes, D., Craig, W. A.
Publicado em 2002

Continuous infusion of beta-lactam antibiotics.

Por Craig, W A, Ebert, S C
Publicado em 1992

Pharmacodynamics of the New Des-F(6)-Quinolone Garenoxacin in a Murine Thigh Infection Model

Por Andes, D., Craig, W. A.
Publicado em 2003

Pharmacodynamics of a New Streptogramin, XRP 2868, in Murine Thigh and Lung Infection Models

Por Andes, D., Craig, W. A.
Publicado em 2006

Pharmacodynamics of a New Cephalosporin, PPI-0903 (TAK-599), Active against Methicillin-Resistant Staphylococcus aureus in Murine Thigh and Lung Infection Models: Identification of...

Por Andes, D., Craig, W. A.
Publicado em 2006

Pharmacodynamics of a New Cephalosporin, PPI-0903 (TAK-599), Active against Methicillin-Resistant Staphylococcus aureus in Murine Thigh and Lung Infection Models: Identification of...

Por Andes, D., Craig, W. A.
Publicado em 2014

Enhancing effect of serum ultrafiltrate on the activity of cephalosporins against gram-negative bacilli.

Por Leggett, J E, Craig, W A
Publicado em 1989

In Vivo Pharmacodynamics of Ceftobiprole against Multiple Bacterial Pathogens in Murine Thigh and Lung Infection Models

Por Craig, W. A., Andes, D. R.
Publicado em 2008

In Vivo Activities of Ceftolozane, a New Cephalosporin, with and without Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae, Including Strains with Extended-Spectrum...

Por Craig, W. A., Andes, D. R.
Publicado em 2013

In Vivo Pharmacodynamic Activity of Daptomycin

Por Safdar, Nasia, Andes, David, Craig, W. A.
Publicado em 2004

In Vivo Pharmacodynamics of New Lipopeptide MX-2401

Por Craig, W. A., Andes, D. R., Stamstad, T.
Publicado em 2010

Correlation between in vitro and in vivo activity of antimicrobial agents against gram-negative bacilli in a murine infection model.

Por Fantin, B, Leggett, J, Ebert, S, Craig, W A
Publicado em 1991

In Vivo Pharmacodynamics of a New Oxazolidinone (Linezolid)

Por Andes, D., van Ogtrop, M. L., Peng, J., Craig, W. A.
Publicado em 2002

Pharmacokinetics of Minocycline in Renal Failure

Por Welling, P. G., Shaw, W. R., Uman, S. J., Tse, F. L. S., Craig, W. A.
Publicado em 1975

Impact of MIC Range for Pseudomonas aeruginosa and Streptococcus pneumoniae on the Ceftolozane In Vivo Pharmacokinetic/Pharmacodynamic Target

Por Lepak, A. J., Reda, A., Marchillo, K., Van Hecker, J., Craig, W. A., Andes, D.
Publicado em 2014

Pharmacokinetics and pharmacodynamics of cefoperazone-sulbactam in patients on continuous ambulatory peritoneal dialysis.

Por Johnson, C A, Zimmerman, S W, Reitberg, D P, Whall, T J, Leggett, J E, Craig, W A
Publicado em 1988

Lipid X protects mice against fatal Escherichia coli infection.

Por Golenbock, D T, Leggett, J E, Rasmussen, P, Craig, W A, Raetz, C R, Proctor, R A
Publicado em 1988

Pharmacokinetics of cefuroxime in normal and impaired renal function: comparison of high-pressure liquid chromatography and microbiological assays.

Por Bundtzen, R W, Toothaker, R D, Nielson, O S, Madsen, P O, Welling, P G, Craig, W A
Publicado em 1981